Nanite offers genetic drug delivery with AI-driven polymer design and multiplexed in vivo screening to develop nanoparticles for tissue-specific delivery. Their innovative platform, SAYER, integrates high-throughput synthesis, biology, materials science, and AI to create safe and resorbable polymer nanoparticles (PNPs). These PNPs offer advantages over traditional viral vectors and lipid nanoparticles, providing a safer and more efficient method for gene therapy.
📋 Overview of Nanite
📙 About Nanite
💰 Recent Investors of Nanite
Arkitekt Ventures, Cystic Fibrosis Foundation, Investor
© 2025 Bot Memo. All Rights Reserved.
